Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis (Q40098919)

17 September 2017

title

Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis (English)

1 reference

17 September 2017

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sang-Heon Song

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Kyong-Hwa Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yoon Ji Choi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kwan-Woo Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Chang Ho Kang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jong Hoon Park

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

30 June 2016

1 reference

Japanese Journal of Clinical Oncology

17 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

845-849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Fibromatosis of the head and neck: a challenging lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Individualizing management of aggressive fibromatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Endocrine therapy for desmoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Combination chemotherapy in adult desmoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Activity of Sorafenib against desmoid tumor/deep fibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Low-dose chemotherapy of desmoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYW081

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYW081

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365524%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference